Ascletis Pharma's IPO

Ascletis Pharma raised a round of funding on August 01, 2018. Investors include Public.

Ascletis Pharma (歌礼生物科技) (HKG: 1672) is a biotechnology company dedicated to discovering, developing and commercializing new treatments for infectious diseases, such as HCV, HIV and HBV, a…

Articles about Ascletis Pharma's IPO: